Henry Schein reports strong 2026 Q3 and raises FY2026 guidance

November 3, 2026- Henry Schein, Inc. reported financial results for the third quarter ended September 26, 2026. The Company reported $3.5 billion in sales with total growth of 4.0%, and 3.1% internally in local currencies. GAAP earnings per share grew 26.2% versus the prior year. Non-GAAP earnings per share grew 13.0%, or 19.1% when excluding current-quarter net tariff refunds and the prior-year remeasurement gains.

Third Quarter 2026 Financial Results

  • Total net sales for the quarter were $3.5 billion, an increase of 4.0% in total compared to the third quarter of 2025, reflecting 3.1% internal sales growth, 0.7% sales growth from acquisitions, and a 0.2% increase resulting from foreign currency exchange.
  • Global Distribution and Value-Added Services sales for the quarter increased 3.7% in total, reflecting 2.9% internal sales growth, 0.5% sales growth from acquisitions, and a 0.3% increase from foreign currency exchange compared with the third quarter of 2025. The main components compared with the third quarter of 2025 are:
    • Global Medical Distribution sales for the quarter increased 1.1% in total, and by 1.0% internal sales growth, compared with the third quarter of 2025.
    • Global Value-Added Services sales for the quarter decreased 4.8%, on both a reported and internal sales growth basis, compared with the third quarter of 2025.

Continue Reading here.

safe online pharmacy for cheap kamagra oral jelly online